Goldman Sachs’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Sell |
|
|||||
|
2025
Q1 | $13.1M | Sell |
|
|||||
|
2024
Q4 | $15.7M | Sell |
|
|||||
|
2024
Q3 | $17.7M | Buy |
|
|||||
|
2024
Q2 | $12.9M | Buy |
|
|||||
|
2024
Q1 | $10.8M | Buy |
|
|||||
|
2023
Q4 | $18.4M | Buy |
|
|||||
|
2023
Q3 | $11.4M | Sell |
|
|||||
|
2023
Q2 | $16.9M | Buy |
|
|||||
|
2023
Q1 | $10.8M | Buy |
|
|||||
|
2022
Q4 | $2.03M | Sell |
|
|||||
|
2022
Q3 | $3.57M | Sell |
|
|||||
|
2022
Q2 | $7.24M | Buy |
|
|||||
|
2022
Q1 | $3.83M | Buy |
|
|||||
|
2021
Q4 | $6.25M | Buy |
|
|||||
|
2021
Q3 | $3.9M | Buy |
|
|||||
|
2021
Q2 | $2.22M | Sell |
|
|||||
|
2021
Q1 | $3.89M | Buy |
|
|||||
|
2020
Q4 | $2.37M | Sell |
|
|||||
|
2020
Q3 | $2.65M | Sell |
|
|||||
|
2020
Q2 | $4.37M | Sell |
|
|||||
|
2020
Q1 | $8.86M | Sell |
|
|||||
|
2019
Q4 | $12.6M | Sell |
|
|||||
|
2019
Q3 | $8.83M | Buy |
|
|||||
|
2019
Q2 | $7.47M | Sell |
|
|||||
|
2019
Q1 | $8.96M | Sell |
|
|||||
|
2018
Q4 | $11.3M | Sell |
|
|||||
|
2018
Q3 | $11.6M | Sell |
|
|||||
|
2018
Q2 | $10.3M | Buy |
|
|||||
|
2018
Q1 | $6.45M | Buy |
|
|||||
|
2017
Q4 | $5.41M | Buy |
|
|||||
|
2017
Q3 | $5.49M | Sell |
|
|||||
|
2017
Q2 | $5.37M | Buy |
|
|||||
|
2017
Q1 | $2.54M | Sell |
|
|||||
|
2016
Q4 | $2.68M | Buy |
|
|||||
|
2016
Q3 | $1.13M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $61K | Buy |
|